Filter Results
:
(521)
Show Results For
-
All HBS Web
(521)
- People (2)
- News (133)
- Research (127)
- Events (2)
- Multimedia (5)
- Faculty Publications (71)
Show Results For
-
All HBS Web
(521)
- People (2)
- News (133)
- Research (127)
- Events (2)
- Multimedia (5)
- Faculty Publications (71)
- 01 Jun 2003
- News
Student Conferences, at a Glance
Jurvetson; Jeffrey C. Walker (MBA 1981), managing general partner, JPMorgan Partners; Stephen A. Schwarzman (MBA 1972), founding partner, president, & CEO, The Blackstone Group Fewer but better biotech companies are being funded with...
View Details
- 20 Jul 2015
- Research & Ideas
Globalization Hasn’t Killed the Manufacturing Cluster
the federal government to create new clusters in the United States. He points to the rise of biotech in Harvard's backyard, which began despite government opposition in the 1970s. Clusters "tend to emerge much more organically, and they...
View Details
- 06 Feb 2007
- First Look
First Look: February 6, 2007
Harvard Business School Supplement 107-049 Supplements the (A) case. Purchase this supplement: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=107049 Monsanto: Realizing Biotech Value in Brazil Harvard Business School Case...
View Details
Keywords:
Martha Lagace
- 17 Oct 2006
- First Look
First Look: October 17, 2006
founded by a young venture capitalist and a university professor to exploit recombinant DNA technology. Thirty years and more than $300 billion in investments later, only a handful of biotech firms have matched Genentech's success or even...
View Details
Keywords:
Sean Silverthorne
- 24 May 2011
- First Look
First Look: May 24
case:http://cb.hbsp.harvard.edu/cb/product/211086-PDF-ENG Innovation and Growth at Actelion Ltd Gary P. Pisano, Daniela Beyersdorfer, and Ruth DittrichHarvard Business School Case 611-065 : In late 2010, Jean-Paul Clozel, CEO of the Swiss View Details
Keywords:
Sean Silverthorne
- 19 Mar 2006
- Research & Ideas
Unlocking Your Investment Capital
Neither an asset's cost nor its size specifies its riskiness. For example, consider two assets, $1 billion of a single-drug biotech stock and $1 billion of U.S. Treasury bonds: Each has the same cost and size but they have radically...
View Details
- Web
Celebrating Latinx Heritage Month at HBS - MBA
Government Health Care / BioTech Manufacturing Private Equity Real Estate Retail Social Enterprise Technology Venture Capital Audiences Audiences FirstGen+ College Diverse Perspectives International LGBTQ+ Military Socioeconomic Inclusion...
View Details
- 08 Sep 2010
- First Look
First Look: September 8, 2010
for a cure; the doubts and obstacles he experiences along the way; and the current options Kremer faces, from returning home to spend time with family to founding a new biotech venture. Through this stark, realistic, and inspiring...
View Details
Keywords:
Sean Silverthorne
- 05 Aug 2016
- News
Accelerating Change on Medicine’s Final Frontier
program had two origins: Princeton engineering lecturer James Shinn (MBA 1981) and biotech entrepreneur Gregory Stock (MBA 1987), the brother of one of Amadio’s biology professors. “They impressed upon me how interesting it would be to...
View Details
Keywords:
Robert S. Benchley
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
four-and-a-half year period. Problems involved everything from biotech to consumer products and agrochemicals. Thanks to broadcasting, nearly one-third of the previously unsolved problems found successful solutions. "Innovations...
View Details
Keywords:
by Martha Lagace
- Web
Annual Report 2016 - Annual Report 2016
products giant Faber-Castell and ARRI, the world’s largest manufacturer of professional motion picture equipment. Expanding the I-Lab Ecosystem Work begins on the Pagliuca Harvard Life Lab, a new facility that will offer shared space for high-potential life sciences...
View Details
- 01 Sep 2008
- News
Balanced Equation
significantly. However, we remain a service organization helping entrepreneurs with disruptive technologies that create or transform business. KPCB has always focused on biotech and information technologies. Today we’ve added energy...
View Details
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
prescription drugs that in 1992 it spun off its remaining chemical business to its stockholders. In addition, the American Cyanamid purchase included Immunex, one of the very few biotech startups that had surpassed $100 million in...
View Details
- 01 Oct 2000
- News
The Entrepreneurial Venture
instance, who are the customers, and how do they make decisions? O'Lear: I have been involved in microeconomic (company specific) upheaval. Prior to starting a company with two others, I worked at two high-tech companies: a privately held cardiac ultrasound imaging...
View Details
- 07 Oct 2014
- First Look
First Look: October 7
(MMRC), and brought together a diverse body of academics, researchers, pharmaceutical and biotech companies, physicians, and patients to combine their efforts around the disease. The MMRF had helped facilitate clinical trials for...
View Details
Keywords:
Sean Silverthorne
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
asking, is this the right business model? But there are no answers. The market and technology are constantly changing," Riesenfeld remarks. Important Sounding Board The biotech industry presents similar challenges in a space littered with...
View Details
- 01 Jun 2011
- News
The Best-Laid Plans
deals with Bed Bath & Beyond, Frontier Airlines, and Johnson & Johnson. “You’re always asking, is this the right business model? But there are no answers. The market and technology are constantly changing,” Riesenfeld remarks. The biotech...
View Details
- 01 Mar 2011
- News
Making Their Way
firm. But when her father fell ill in 1986, the Brownells decided to return to Detroit to help with the family enterprise founded by her great-grandfather. As things turned out, Brownell’s father recovered and was able to continue with the company. But Brownell, who in...
View Details
- 29 Oct 2000
- Research & Ideas
The Entrepreneurial Venture: A Conversation
decisions? O'Lear: I have been involved in microeconomic (company specific) upheaval. Prior to starting a company with two others, I worked at two high-tech companies: a privately held cardiac ultrasound imaging company and a VC-backed View Details
Keywords:
by Susan Young
- Web
Global Activities 2020-2021 - Global Activities 2021
Harvard Medical School through the Harvard Department of Stem Cell and Regenerative Biology—to explore biotech careers in emerging markets, particularly in the Middle East and North Africa region. Her family’s difficulty obtaining health...
View Details